Online CME
    Center for Continuing Education

CME General Information

go to all online cme
General Information Course Presentations CME Posttest

2009/10 (October 2009): The Oncology Pharmacist
CIK 10257
Prediction and Promise: KRAS and Colorectal Cancer


Course Objectives Target Audience Method of Participation
Accreditation Term of Approval Disclosure
Disclaimer                                                

Course Objectives
After completing this activity, the reader should be better able to:
• Explain the rationale for studying the effect of KRAS mutations in patients with metastatic colorectal cancer
• Discuss how KRAS mutations affect response to epidermal growth factor receptor (EGFR) inhibitor therapy in patients with metastatic colorectal cancer
• Describe common toxicities associated with use of anti-EGFR monoclonal antibodies and measures that can be taken to prevent and manage them
• Explain how use of biomarkers such as KRAS mutations to select therapy can lead to more cost-effective treatment of patients with cancer
top
To Receive A Certificate
Review the material in the Course Presentations section.
Complete the CME Posttest with a score of 7 out of 10 questions correct.
You will then be asked to register and complete a brief course evaluation.
A certificate will be automatically generated for you online.
Target Audience
Registered pharmacists and other interested healthcare professionals, especially those caring for cancer patients.
top
Method of Participation
To receive continuing education credit, learners must:
- Read the article in its entirety
- Take the CE self-assessment test and complete the evaluation

Please note: The learner must answer at least 70% of the questions on the post-test correctly.

The estimated time to complete this activity is 1 hour.

Your continuing education certificate can be printed by following the directions online after successful completion of the post-test and evaluation.
top
Accreditation
acpe logoThe University of Nebraska Medical Center, Center for Continuing Education is accredited by the Ac creditation Council for Pharmacy Education as a provider of continuing pharmacy education. The ACPE provider number is 0447-0000-078-H04-P. To receive the 1 contact hour of continuing education credit, pharmacists should complete the activity requirements and evaluation at the conclusion of the activity. Approval is valid from the initial release date of October 15, 2009. The expiration date is October 14, 2010. A statement of credit will be available for printing online upon completion of the post-test with a score of 70% or better and the evaluation instrument.
top
Term of Approval
Release Date: October 15, 2009
Expiration Date: October 14, 2010
top
Disclosure
Please refer to printed October 2009 issue of The Oncology Pharmacist.
top
Disclaimer
The opinions or views expressed in this continuing education activity are those of the faculty and do not necessarily reflect the opinions or recommendations of the University of Nebraska Medical Center (UNMC), Center for Continuing Education.

While the University of Nebraska Medical Center, Center for Continuing Education is an ACPE-accredited organization, this does not imply endorsement by the UNMC or ACPE of any commercial products affiliated with this activity.
top